active
ACTIVE SINCE: 2024

Sanofi Global Health Unit – University of Rwanda: Clinical Trials Training Programme in Rwanda

The Clinical Trial Training Program at the University of Rwanda offers training in clinical trial design, focusing on good clinical practice. Over five years, it will progress from certificates to a master's degree, boosting oncology trial capacity. Sanofi funds the first year, with additional support from the International Vaccine Institute.
SDGS CONTRIBUTING TO:
SHOW SUB-TARGETS + HIDE SUB-TARGETS -
MEMBER COMPANIES:
Academia or research institute 4
Objectives

Support the University of Rwanda, working with the Karolinska Institute, Stockholm Sweden and the Centre for Innovative Drug Discovery and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Ethiopia, to establish an academic training programme on Clinical Research in Rwanda Kigali. This will strengthen the education and training of healthcare professionals and scientists in Rwanda, including those delivering oncology specialist care, in clinical trials and biomedical research.

The Clinical Trial Training Program will provide a comprehensive and sustainable training in clinical trial design, conduct, and management, with a particular focus on good clinical practice (GCP) and regulatory compliance. The programme will consist of a stepwise approach. Initially, there will be a one-year hybrid training modules at UR, with a “teach the teachers” approach for sustainable capacity strengthening to conduct clinical trials. The programme will progress in status over five years through Certificate, Diploma and ultimately a Masters in Clinical Research award.

During the first three years of the course it is anticipated that 6 oncologists, 3 pathologists and 3 radiologists will undertake the training, leading to an increased capacity for clinical trials in Rwanda’s oncology centers as part of routine practice, with the benefit to patients derived from increased participation in clinical trials. The selected trainees will also be empowered to deliver the training to others in their institutions to support sustainability and permanence.

Sanofi’s support is specifically to the first year of this three-year period, covering the initial phase of establishment of the course in the University of Rwanda. The University has secured additional funding form the International Vaccine Institute in Seoul, South Korea.

Results and milestones
  • Transfer of technical knowledge from the Karolinska Institute, Stockholm, Sweden, and CDT-Africa, Addis Ababa commenced in 2024
  • The first intake of students completing initial training modules is expected in 2024/25
Geographic Reach
Disease Area
Partner organizations
Academia or research institute

International Vaccine Institute

Karolinska Institute

University of Rwanda

Centre for Innovative Drug Discovery and Therapeutic Trials for Africa (CDT-Africa)